Abstract
The chemical structure of vitamin D resembles steroids and anabolics. Following activation by enzymatic hydroxylation, vitamin D enhances numerous body functions. We determined 25-hydroxy-vitamin D, number of erythrocytes, haematocrit, mean corpuscular haemoglobin and mean corpuscular volume in 97 patients with multiple sclerosis initially and 6 months later. Patients with deficient levels of 25-hydroxyvitamin D (< 30 ng/mL) were advised to perform vitamin D supplementation and received a prescription of a vitamin D formulation. Six months later we observed a rise of 25-OH-vitamin D, as to be expected, and a modified constellation of blood parameters such as elevation of mean corpuscular haemoglobin concentration and fall of mean corpuscular volume. Mean corpuscular haemoglobin and number of erythrocytes remained stable. The haematocrit went down. We suggest that vitamin D elevation may be beneficial in disorders characterised by chronic neuroinflammation and neurodegeneration, since changes of blood perfusion parameters may enhance cellular tissue oxygenation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Brola W, Sobolewski P, Szczuchniak W, Goral A, Fudala M, Przybylski W, Opara J (2016) Association of seasonal serum 25-hydroxyvitamin D levels with disability and relapses in relapsing-remitting multiple sclerosis. Eur J Clin Nutr 70:995–999
Glueck CJ, Jetty V, Rothschild M, Duhon G, Shah P, Prince M, Lee K, Goldenberg M, Kumar A, Goldenberg N, Wang P (2016) Associations between serum 25-hydroxyvitamin D and lipids, lipoprotein cholesterols, and homocysteine. N Am J Med Sci 8:284–290
Kheiri B, Abdalla A, Osman M, Ahmed S, Hassan M, Bachuwa G (2018) Vitamin D deficiency and risk of cardiovascular diseases: a narrative review. Clin Hypertens 24:9
Kueider AM, Tanaka T, An Y, Kitner-Triolo MH, Palchamy E, Ferrucci L, Thambisetty M (2016) State- and trait-dependent associations of vitamin-D with brain function during aging. Neurobiol Aging 39:38–45
Lang E, Jilani K, Bissinger R, Rexhepaj R, Zelenak C, Lupescu A, Lang F, Qadri SM (2015) Vitamin D-rich diet in mice modulates erythrocyte survival. Kidney Blood Press Res 40:403–412
Larsson SC, Flicker L (2019) Vitamin D: a novel protective factor for delirium? Neurology 92:553–554
Lerchbaum E, Pilz S, Trummer C, Schwetz V, Pachernegg O, Heijboer AC, Obermayer-Pietsch B (2017) Vitamin D and testosterone in healthy men: a randomized controlled trial. J Clin Endocrinol Metab 102:4292–4302
Matias-Guiu J, Oreja-Guevara C, Matias-Guiu JA, Gomez-Pinedo U (2016) Vitamin D and remyelination in multiple sclerosis. Neurologia 33(3):177–186
Mielgo-Ayuso J, Calleja-Gonzalez J, Urdampilleta A, Leon-Guereno P, Cordova A, Caballero-Garcia A, Fernandez-Lazaro D (2018) Effects of vitamin D supplementation on haematological values and muscle recovery in elite male traditional rowers. Nutrients 10(12):e1986
Müller T, Barghorn S, Lütge S, Haas T, Müller R, Gerlach B, Öhm G, Eilert K, Trommer I, Mueller BK (2015) Decreased levels of repulsive guidance molecule A in association with beneficial effects of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients. J Neural Transm (Vienna) 122:841–848
Müller T, Trommer I, Muhlack S, Müller BK (2016) Levodopa increases oxidative stress and repulsive guidance molecule A levels: a pilot study in patients with Parkinson’s disease. J Neural Transm (Vienna) 123:401–406
Muris AH, Smolders J, Rolf L, Thewissen M, Hupperts R, Damoiseaux J (2016) Immune regulatory effects of high dose vitamin D3 supplementation in a randomized controlled trial in relapsing remitting multiple sclerosis patients receiving IFNbeta; the SOLARIUM study. J Neuroimmunol 300:47–56
Pihl-Jensen G, Frederiksen JL (2015) 25-Hydroxyvitamin D levels in acute monosymptomatic optic neuritis: relation to clinical severity, paraclinical findings and risk of multiple sclerosis. J Neurol 262:1646–1654
Schlogl M, Holick MF (2014) Vitamin D and neurocognitive function. Clin Interv Aging 9:559–568
Shoemaker TJ, Mowry EM (2018) A review of vitamin D supplementation as disease-modifying therapy. Mult Scler 24:6–11
Siotto M, Filippi MM, Simonelli I, Landi D, Ghazaryan A, Vollaro S, Ventriglia M, Pasqualetti P, Rongioletti MCA, Squitti R, Vernieri F (2019) Oxidative stress related to iron metabolism in relapsing remitting multiple sclerosis patients with low disability. Front Neurosci 13:86
Tanabe S, Fujita Y, Ikuma K, Yamashita T (2018) Inhibiting repulsive guidance molecule-a suppresses secondary progression in mouse models of multiple sclerosis. Cell Death Dis 9:1061
Wise J (2015) Low vitamin D is linked to faster cognitive decline in older adults. BMJ 351:h4916
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Müller, T., Lohse, L., Blodau, A. et al. Vitamin D rise enhances blood perfusion in patients with multiple sclerosis. J Neural Transm 126, 1631–1636 (2019). https://doi.org/10.1007/s00702-019-02093-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-019-02093-x